A recent study has identified Galectin-3 as a potential LPS sensor, through which LPS can modulate glucose metabolism via the LPS/Galectin-3/Rag GTPases/Ragulator-mTORC1 axis, thereby participating in the regulation of HCC (Chen X. et al., 2022). The gene discussed is LGALS3; the disease is hepatocellular carcinoma.